Ticker > Company >

Fortis MalarHospital share price

Fortis Malar Hospitals Ltd.

BSE: 523696 SECTOR: Hospital & Healthcare Services  29.65 K   32   4

68.35
+0.99 (1.47%)
BSE: 02 Sep 04:01 PM

Price Summary

Today's High

₹ 68.5

Today's Low

₹ 67.2

52 Week High

₹ 98.7

52 Week Low

₹ 51.01

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

128.1 Cr.

Enterprise Value

110.4 Cr.

No. of Shares

1.87 Cr.

P/E

27.58

P/B

3.75

Face Value

₹ 10

Div. Yield

62.18 %

Book Value (TTM)

₹  18.21

CASH

17.7 Cr.

DEBT

0 Cr.

Promoter Holding

62.71 %

EPS (TTM)

₹  2.48

Sales Growth

-100%

ROE

0.59 %

ROCE

0.86%

Profit Growth

-99.13 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-100%
3 Year-100%
5 Year-100%

Profit Growth

1 Year-99.13%
3 Year27.02%
5 Year15.39%

ROE%

1 Year0.59%
3 Year11.21%
5 Year2.94%

ROCE %

1 Year0.86%
3 Year21.71%
5 Year11.66%

Debt/Equity

0

Price to Cash Flow

72.34

Interest Cover Ratio

58.4412

CFO/PAT (5 Yr. Avg.)

0.364229418748579

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 62.71 0.00
Mar 2025 62.71 0.00
Dec 2024 62.71 0.00
Sep 2024 62.71 0.00
Jun 2024 62.71 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 27.0202889588308% for the Past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • Company has a healthy liquidity position with current ratio of 5.146.
  • The company has a high promoter holding of 62.71%.

 Limitations

  • The company has shown a poor revenue growth of -100% for the Past 3 years.
  • Company has contingent liabilities of 10.5976 Cr.
  • The company has a low EBITDA margin of -0.362294228551068% over the past 5 years.
  • The company is trading at a high PE of 27.58.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 0 0 0 0 0
Total Expenditure 0.89 0.46 0.4 0.37 0.3
Operating Profit -0.89 -0.46 -0.4 -0.37 -0.3
Other Income 0.83 0.56 0.56 0.77 4.61
Interest 0.01 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.06 0.09 0.15 0.4 4.31
Tax 0 0 0.14 0.04 0.13
Profit After Tax -0.06 0.09 0.01 0.36 4.18
Adjusted EPS (Rs) -0.03 0.05 0.01 0.19 2.23

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 69.24 86.18 85.95 59.01 0
Total Expenditure 75.57 82.73 81.37 60.2 2.12
Operating Profit -6.32 3.45 4.58 -1.19 -2.12
Other Income 8.08 7.33 6.56 8.87 2.72
Interest 7.2 6.56 6.07 4.3 0.01
Depreciation 12.88 12.53 12.15 9.36 0
Exceptional Items 6.85 0 0 57.93 0
Profit Before Tax -11.47 -8.31 -7.08 51.95 0.59
Tax -3.45 0 8.46 4.67 0.18
Net Profit -8.01 -8.31 -15.53 47.28 0.41
Adjusted EPS (Rs.) -4.28 -4.43 -8.29 25.23 0.22

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 18.76 18.76 18.76 18.76 18.76
Total Reserves 67.86 59.21 43.2 90.45 11.21
Borrowings 0 0 0 0 0
Other N/C liabilities 47.21 40.89 42.06 0 0
Current liabilities 24.71 31.35 31.67 6.18 6.61
Total Liabilities 158.53 150.22 135.69 115.39 36.57
Assets
Net Block 68.52 57.62 47.41 0 0
Capital WIP 0.36 0 0 0 0
Intangible WIP 0 0.06 0 0 0
Investments 0.05 0.05 0.05 0.05 0.05
Loans & Advances 31.59 45.49 5.9 2.37 2.51
Other N/C Assets 0 0 0 0 0
Current Assets 58 47 82.33 112.97 34.02
Total Assets 158.53 150.22 135.69 115.39 36.57
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -11.47 -8.31 -7.08 51.95 0.59
Adjustment 5.52 11.84 11.71 -53.38 -2.72
Changes in Assets & Liabilities -6.91 3.94 0.88 -0.78 0.63
Tax Paid 11.66 -0.68 0.1 -5 3.27
Operating Cash Flow -1.2 6.8 5.61 -7.21 1.77
Investing Cash Flow -27.6 8.18 0.43 119.62 -27.3
Financing Cash Flow -7.25 -10.1 -12.65 -10.85 -79.65
Net Cash Flow -36.05 4.87 -6.61 101.56 -105.18

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 62.71 62.71 62.71 62.71 62.71
fortis hospitals limited 62.71 62.71 62.71 62.71 62.71
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 37.29 37.29 37.29 37.29 37.29
a m gopalan 1.23 1.23 1.23 1.23 1.23
investor education and pr... - 5.00 5.00 5.00 5.00
ruckmani natarajan 2.07 2.07 2.07 2.07 2.07
sunita kantilal vardhan 1.32 1.32 1.32 1.32 1.27
nithya ramamurthy 4.03 1.94 - - -
investor education and pr... 5.00 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Fortis MalarHospital - Quaterly Results 4 Aug, 5:47 PM Fortis MalarHospital - Quaterly Results 4 Aug, 5:47 PM Fortis MalarHospital - Quaterly Results 4 Aug, 5:47 PM Fortis Malar Hospitals informs about newspaper publication 3 Jul, 4:52 PM Fortis Malar Hospitals informs about press release 16 May, 5:00 PM Fortis MalarHospital - Quaterly Results 15 May, 2:39 PM Fortis MalarHospital - Quaterly Results 15 May, 2:39 PM Fortis MalarHospital - Quaterly Results 15 May, 2:39 PM Fortis MalarHospital - Quaterly Results 3 Feb, 4:30 PM Fortis MalarHospital - Quaterly Results 3 Feb, 4:30 PM Fortis MalarHospital - Quaterly Results 3 Feb, 4:30 PM Fortis Malar Hospitals informs about compliance certificate 14 Jan, 4:39 PM Fortis Malar Hospitals informs about loss of share certificates 29 Nov, 5:53 PM Fortis Malar Hospitals informs about newspaper advertisements 6 Nov, 5:28 PM Fortis MalarHospital - Quaterly Results 5 Nov, 6:18 PM Fortis MalarHospital - Quaterly Results 5 Nov, 6:18 PM Fortis MalarHospital - Quaterly Results 22 Jul, 8:39 PM Fortis MalarHospital - Quaterly Results 22 Jul, 8:39 PM Fortis Malar Hospitals informs about updates 18 May, 11:29 AM Fortis MalarHospital - Quaterly Results 17 May, 8:05 PM Fortis MalarHospital - Quaterly Results 17 May, 8:05 PM Fortis MalarHospital - Quaterly Results 5 Feb, 6:10 PM Fortis MalarHospital - Quaterly Results 5 Feb, 6:10 PM Fortis MalarHospital - Quaterly Results 5 Feb, 6:10 PM Fortis Malar Hospitals informs about compliances-certificate 18 Jan, 5:08 PM Fortis Malar Hospitals informs about compliances-certificate 15 Jan, 1:29 PM Fortis Malar Hospitals informs about disclosure 29 Nov, 12:23 PM Fortis Malar Hospitals informs about loss of share certificates 29 Nov, 10:52 AM Fortis Malar Hospitals inks business transfer agreement with MGM Healthcare 24 Nov, 4:38 PM Fortis MalarHospital - Quaterly Results 6 Nov, 4:28 PM Fortis MalarHospital - Quaterly Results 6 Nov, 4:28 PM Fortis MalarHospital - Quaterly Results 6 Nov, 4:28 PM Fortis Malar Hospitals informs about issuance of duplicate share certificates 4 Sep, 12:32 PM Fortis MalarHospital - Quaterly Results 2 Aug, 6:59 PM Fortis MalarHospital - Quaterly Results 2 Aug, 6:59 PM Fortis Malar Hospitals submits Newspaper Publication 8 Jul, 4:42 PM Fortis Malar Hospitals informs about annual secretarial compliance report 22 May, 1:29 PM Fortis Malar Hospitals informs about RPT disclosure 20 May, 12:34 PM Fortis MalarHospital - Quaterly Results 19 May, 5:38 PM Fortis MalarHospital - Quaterly Results 19 May, 5:38 PM Fortis Malar Hospitals informs about issuance of duplicate share certificate 27 Feb, 12:29 PM Fortis Malar Hospitals informs about newspaper advertisements 9 Feb, 10:04 AM Fortis MalarHospital - Quaterly Results 7 Feb, 6:40 PM Fortis MalarHospital - Quaterly Results 7 Feb, 6:40 PM Fortis Malar Hospitals informs about board meeting 31 Jan, 3:01 PM Fortis Malar Hospitals informs about certificate 6 Jan, 4:51 PM Fortis Malar Hospitals informs about loss of certificates 2 Dec, 4:45 PM Fortis Malar Hospitals informs about newspaper publication 9 Nov, 3:55 PM Fortis MalarHospital - Quaterly Results 7 Nov, 5:33 PM Fortis MalarHospital - Quaterly Results 7 Nov, 5:33 PM

Fortis MalarHospital Stock Price Analysis and Quick Research Report. Is Fortis MalarHospital an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Fortis MalarHospital. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Fortis MalarHospital has a PE ratio of 27.5838411558174 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Fortis MalarHospital has ROA of 0.5396% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Fortis MalarHospital has a Current ratio of 5.146.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Fortis MalarHospital has a ROE of 0.5893%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Fortis MalarHospital has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Fortis MalarHospital has reported revenue growth of -100% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Fortis MalarHospital for the current financial year is 0%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Fortis MalarHospital is Rs 42.5 and the yield is 62.6566%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Fortis MalarHospital is Rs 2.4779. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Fortis MalarHospital in Ticker for free. Also, one can get the intrinsic value of Fortis MalarHospital by using Valuation Calculators, which are available with a Finology ONE subscription. 

Fortis MalarHospital FAQs

Q1. What is Fortis MalarHospital share price today?
Ans: The current share price of Fortis MalarHospital is Rs 68.35.

Q2. What is the market capitalisation of Fortis MalarHospital?
Ans: Fortis MalarHospital has a market capitalisation of Rs 128.099922765 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Fortis MalarHospital?
Ans: The PE ratio of Fortis MalarHospital is 27.5838411558174 and the P/B ratio of Fortis MalarHospital is 3.75374138451822, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Fortis MalarHospital share?
Ans: The 52-week high share price of Fortis MalarHospital is Rs 98.7, and the 52-week low share price of Fortis MalarHospital is Rs 51.01.

Q5. Does Fortis MalarHospital pay dividends?
Ans: Currently, Fortis MalarHospital pays dividends. Dividend yield of Fortis MalarHospital is around 62.6566%.

Q6. What are the face value and book value of Fortis MalarHospital shares?
Ans: The face value of Fortis MalarHospital shares is Rs 10, while the book value per share of Fortis MalarHospital is around Rs 18.2085. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Fortis MalarHospital?
Ans: Fortis MalarHospital has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Fortis MalarHospital?
Ans: The ROE of Fortis MalarHospital is 0.5893% and ROCE of Fortis MalarHospital is 0.8566%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Fortis MalarHospital a good buy for the long term?
Ans: The Fortis MalarHospital long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Fortis MalarHospital undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Fortis MalarHospital appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Fortis MalarHospital’s financials?
Ans: You can review Fortis MalarHospital’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Fortis MalarHospital
X